Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784960 · ClinicalTrials.gov registry record · NA
Communication Strategies to Increase HPV Vaccination Intention
A NA study of Communication and Vaccine Hesitancy, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- NA
- Development phase
- 3,689
- Enrollment target
- 1
- Study location
NCT06784960: Recruiting NA study of Communication and Vaccine Hesitancy, sponsored by University of Pennsylvania.
NCT06784960 is a NA study of Communication and Vaccine Hesitancy that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 3,689 participants, above the 1,312-participant average among 34 other Communication trials with a reported enrollment target (181% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06784960, a NA study of Communication and Vaccine Hesitancy, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- NA
- Development phase
- 3,689 participants
- Enrollment target
- 1
- Study location
Study Summary
This research aims to identify communication strategies to improve the uptake of vaccines using an experimental design, focusing on the Human Papillomavirus (HPV) vaccine, which is highly effective in preventing HPV-related cancers. However, low HPV vaccination rates among adults remain a significant public health challenge. Although randomized controlled trials (RCTs) have demonstrated that interventions can increase vaccine uptake in children, few RCTs have been conducted on adults. To address this gap, a multidisciplinary investigative team with expertise in communication, medicine, nursing, and behavior-change intervention research, and a history of extensive collaboration, will conduct a survey experiment on a national sample of over 3,689 adults to identify the most promising theory-based messages to strengthen HPV vaccine intentions.
Primary Outcome
Validated 3-item likert scale assessing HPV vaccination intention.
Conditions Studied
Interventions
- BEHAVIORAL Messages
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,689 participants |
| Start Date | 2025-02-06 |
| Est. Completion | 2026-03 |
| Phase | NA |
What NCT06784960 shows while recruiting
NCT06784960 is an interventional study that assigns participants to a tested intervention. Its 3,689 participants enrollment target places it among the larger protocols in the corpus, above the 1,312-participant average among 34 other Communication trials with a reported enrollment target (181% higher).
The record links to 3 conditions, with Communication appearing as the primary indexed condition, and to 1 intervention - of which Messages is the first listed.
NCT06784960 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06784960 about?
NCT06784960 is a clinical study titled "Communication Strategies to Increase HPV Vaccination Intention". This research aims to identify communication strategies to improve the uptake of vaccines using an experimental design, focusing on the Human Papillomavirus (HPV) vaccine, which is highly effective in preventing HPV-related cancers. However, low HPV vaccination rates among adults remain a significan...
What is the current status of trial NCT06784960?
This trial is currently recruiting. It is a NA study. The enrollment target is 3,689 participants. The study started on 2025-02-06. Estimated completion is 2026-03.
What conditions does trial NCT06784960 study?
This clinical trial studies the following conditions: Communication, Vaccine Hesitancy, Papilloma Viral Infection.
What interventions are being tested in trial NCT06784960?
The interventions under investigation include: Messages (BEHAVIORAL).
Who is sponsoring clinical trial NCT06784960?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784960 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Communication
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06784960's enrollment target sits among peer trials
3,689 5th of 34 higher than 30 of 34 other Communication trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Communication trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Seminar in Unwavering Empowering Presence Optimized for Rehabilitation Teams
RECRUITING · NA
-
Multicenter HomeVENT: Home Values and Experiences Navigation Track
RECRUITING · NA
-
Alcohol and Sexual Communication Among Couples in the Laboratory
RECRUITING · NA
-
Families of Youth with Developmental Disabilities: a Theory-Based Intervention
RECRUITING · NA
-
Timing of Physician Rounds for Antepartum Patients
RECRUITING · NA
-
Together After Cancer
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06401863 · 3,691 participants · NA
Shared Decision for Drug Interactions in Oral Anticoagulation
- NCT06058377 · 3,680 participants · Phase 3
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
- NCT06076304 · 3,720 participants · Phase 4
Nasal Steroids, Irrigation, Oral Antibiotics, and Subgroup Targeting for Effective Management of Acute Sinusitis
- NCT06702553 · 3,650 participants · Phase 3
Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI